Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Kerr

Showing results (41-50 of 221) with videos related to

Pageof 23
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2004
Signal transduction blockade and cancer: combination therapy or multi-targeted inhibitors?D J Kerr, N B La Thangue
BMJ (Clinical Research Ed.)|December 1, 2000
ABC of colorectal cancer: Innovative treatment for colon cancerG A Chung-Faye, D J Kerr
Journal of the Royal Society of Medicine|September 13, 2000
Chemotherapy for colorectal cancerS Nicum, R Midgley, D J Kerr
Anticancer Research|September 1, 1992
The response of breast cancer cells to steroid and peptide growth factorsJ Godden, R Leake, D J Kerr
British Journal of Cancer|September 1, 1996
Delivering cancer care: a model from the West MidlandsD J Kerr, R Griffiths, B Edwards
Cancer Letters|February 1, 1991
Doxorubicin stimulates transcription from the human immunodeficiency virus long terminal repeat sequencesV Zoumpourlis, D J Kerr, D A Spandidos
Anticancer Research|November 1, 1991
The effect of doxorubicin, daunorubicin and 4'-epidoxorubicin on the exogenous c-myc promoter in mouse erythroleukemia cellsA Eliopoulos, D J Kerr, D A Spandidos
Biochemical Pharmacology|February 4, 1992
Carboplatin as opposed to cisplatin does not stimulate the expression of the human immunodeficiency virus long terminal repeat sequencesV Zoumpourlis, D J Kerr, D A Spandidos
European Journal of Cancer (Oxford, England : 1990)|June 1, 1996
Clinical trials of P-glycoprotein reversal in solid tumoursD R Ferry, H Traunecker, D J Kerr
Expert Opinion on Biological Therapy|July 26, 2003
Gene therapy for colorectal cancerD J Kerr, L W Seymour, F Maruta
Pageof 23

Showing results (41-50 of 221) with videos related to

Sort By:
Pageof 23
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2004
Signal transduction blockade and cancer: combination therapy or multi-targeted inhibitors?D J Kerr, N B La Thangue
BMJ (Clinical Research Ed.)|December 1, 2000
ABC of colorectal cancer: Innovative treatment for colon cancerG A Chung-Faye, D J Kerr
Journal of the Royal Society of Medicine|September 13, 2000
Chemotherapy for colorectal cancerS Nicum, R Midgley, D J Kerr
Anticancer Research|September 1, 1992
The response of breast cancer cells to steroid and peptide growth factorsJ Godden, R Leake, D J Kerr
British Journal of Cancer|September 1, 1996
Delivering cancer care: a model from the West MidlandsD J Kerr, R Griffiths, B Edwards
Cancer Letters|February 1, 1991
Doxorubicin stimulates transcription from the human immunodeficiency virus long terminal repeat sequencesV Zoumpourlis, D J Kerr, D A Spandidos
Anticancer Research|November 1, 1991
The effect of doxorubicin, daunorubicin and 4'-epidoxorubicin on the exogenous c-myc promoter in mouse erythroleukemia cellsA Eliopoulos, D J Kerr, D A Spandidos
Biochemical Pharmacology|February 4, 1992
Carboplatin as opposed to cisplatin does not stimulate the expression of the human immunodeficiency virus long terminal repeat sequencesV Zoumpourlis, D J Kerr, D A Spandidos
European Journal of Cancer (Oxford, England : 1990)|June 1, 1996
Clinical trials of P-glycoprotein reversal in solid tumoursD R Ferry, H Traunecker, D J Kerr
Expert Opinion on Biological Therapy|July 26, 2003
Gene therapy for colorectal cancerD J Kerr, L W Seymour, F Maruta
Pageof 23